About Us
Markets
Research
Services
NRI Corner
Fund Transfer
Select Link
MF Back Office-SB
MF Back Office-Client
Back Office - Client
Back Office - Sub Brokers
Backoffice – Family Login
Webmail
SPEEDe Login
BSE STAR MF
Branch Login
Create Account
About Us
Markets
Research
Services
Portfolio
NRI Cornor
Fund Transfer
Company Snapshot
Read it, Learn it and Do it for your investment Needs
Equity
Derivatives
Currency
Mutual Fund
IPO
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Daily market Tracker
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Home > Market > Equity >
Company Snapshot
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Technicals
+12 more
Score Board
Directors Report
MF Holding
Charts
Company News
History
Monthly High Low
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Deliverable Volumes
Share Holdings Pattern
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company Profile
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holdings Pattern
Charts
Company News
Directors Report
History
MF Holdings
Profit & Loss
Monthly High Low
Technicals
Deliverable Volumes
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company Snapshot
Bacil Pharma Ltd
Pharmaceuticals - Indian - Bulk Drugs
BSE Code:
524516
NSE Symbol:
N.A
P/E :
27.11
ISIN Demat:
INE711D01018
Div & Yield %:
0
EPS :
0.46
Book Value:
17.55
Market Cap (Rs. Cr.):
17.90
Face Value :
10
Exchange
BSE
NSE
Stock Price Details
Last Price (₹)
11.85
Change
-0.62 (-4.97%)
Best Buy (₹)
0
Best Sell (₹)
0
Today's Range
11.85 - 11.85
52-Week Range
12.47 - 61.80
Beta (1 Year)
0.30
Chart
1 Day
|
5 Day
|
3 Month
|
1 Year
|
5 Year
Index Details
Corporate Announcements
Bacil Pharma reports standalone net loss of Rs 0.02 crore in the June 2026 quarter>
Bacil Pharma announces board meeting date>
Bacil Pharma to convene board meeting>
Bacil Pharma to convene board meeting>
Bacil Pharma standalone net profit rises 3000.00% in the March 2026 quarter>
Bacil Pharma to conduct board meeting>
Corporate Details
Incorporation Year :
1987
Chairman :
Ownership Group :
Indian Private
Sector :
Pharmaceuticals
Industry :
Pharmaceuticals - Indian - Bulk Drugs
Registered Office :
Bacil Pharma Ltd
G2 & G3 Samarpan Complex,
chakala Andheri East,
Mumbai,
Maharashtra - 400099,
Phone : N.A. ,
Fax : N.A.
E-Mail :
bacilpha@yahoo.com
URL :
http://www.bacilpharma.co.in
Investor Returns
Period
Date
Price(
₹
)
Returns (%)
1Week
10-Aug-2026
16.09
-22.50
1Month
17-Jul-2026
36.43
-65.77
3Month
18-May-2026
54.11
-76.95
6Month
17-Feb-2026
42.42
-70.60
1Year
18-Aug-2025
37.50
-66.75
Mutual Funds Holding
Scheme Name
% Holding
Market Value (₹.Cr)
No Data Found
Peer Groups : Pharmaceuticals - Indian - Bulk Drugs
Company
Last Price(
₹
)
Change(%)
52Week High(
₹
)
52Week Low(
₹
)
Market Cap(
₹
)
Divis Laboratories Ltd
8,600.00
1.24
8,670.50
5,637.50
225,515.56
Neuland Laboratories Ltd
23,319.85
-1.49
23,830.00
11,500.00
30,371.49
Acutaas Chemicals Ltd
3,389.45
5.89
3,735.00
1,290.05
26,205.31
Jubilant Pharmova Ltd
865.30
-0.09
1,183.90
783.75
13,796.18
Gujarat Themis Biosyn Ltd
372.35
5.54
479.45
225.75
3,844.29